Polygene vector system and application thereof
A carrier system and multi-gene technology, applied in the field of molecular biology, can solve problems such as many side reactions, inability to perform reactions in vitro, and high requirements for experimental experience
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2022-05-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of molecular biology, and in particular relates to a multigene carrier system and its application. Background technique
[0002] Gene carrier is one of the important tools of genetic engineering. Traditional vector construction methods include restriction endonuclease and DNA ligase enzyme-cut ligation vector construction method; recombinase-catalyzed homologous recombination exchange construction method.
[0003] The enzyme-cut ligation vector construction method relies on the multiple cloning sites on the vector. Only when the multiple cloning sites on the vector and the target gene match, can the target gene and the vector be ligated after enzyme digestion. However, the number of multiple cloning sites on the vector is limited, so the enzyme-cut ligation method can only meet the vector assembly of a single or a few genes. Homologous recombination methods include λ-att system and Cre-LoxP system. The att site in ...
Examples
Embodiment 1
[0174] The construction of embodiment 1 multigene carrier
[0175] 1. Construct the gene donor vector pGedor containing the target genes H3H, LuZ, and HispS respectively
[0176] 1) Construction of gene donor vector pGedor containing CaMV 35S promoter and NosT terminator
[0177] The schematic diagram of the construction of the gene donor vector pGedor containing 35S promoter and NOS terminator is as follows: image 3 Shown in A: Synthesis of Reco1'(attL1, SEQ ID NO.1)-Rest2(EcoRI, the sequence is GAATTC)-Reco2(attR2,SEQ ID NO.2)-CaMV 35S(SEQ ID NO.3)-NosT(SEQ ID NO.4)-Reco2'(attL2,SEQ ID NO.5) sequence, when synthesizing the sequence, ApaI (sequence is GGGCCC), PstI (sequence is CTGCAG) enzyme cutting sites are synthesized at both ends respectively, in CaMV 35S and A polyclonal fragment MCS (SEQ ID NO.17) containing XbaI (sequence: TCTAGA) and BamHI restriction site (sequence: GGATCC) was synthesized between NosT, and both ends of MSC have the same restriction site MCST (Bs...